The discovery of a new critical enzyme could help engineer climate resilient crops capable of sucking far more carbon dioxide from the atmosphere in a much more efficient way.
Researchers have discovered why malaria parasites are vulnerable to some drug therapies but resistant to others, offering scientists another piece of the puzzle in the global fight against the disease.
A low-cost, non-toxic cancer treatment has been developed by researchers at The Australian National University (ANU). The treatment uses dead bacteria to help kick-start the immune system and shrink cancer.
Researchers from The Australian National University (ANU) have exposed a fatal flaw in the deadly parasite that causes malaria - one of the world's biggest killers.
As you read this abstract, your lungs are (I hope!) bringing live-sustaining oxygen into your body. Oxygen is required by our cells for one key purpose – to act as the final electron acceptor in the mitochondrial electron transport chain (ETC).
Shigella flexneri is an entero-pathogen that is considered a significant public health risk, causing shigellosis or bacillary dysentery, and accounts for the highest percentage of diarrheal deaths annually.
Scientific and technological advancements in the field of cell physiology over the last thirty years have uncovered the identities and functions of over sixty solute carriers which participate in the transport of amino acids in mammalian cells.
Many genes that have been recently identified as determinants of drug resistance in the malaria parasite encode membrane transport proteins (also known as transporters).
Want to get funded? The College Research Office (CRO) in the College of Science is here to help you with that. The CRO provides administrative support at every stage of your funding journey, from pre-to post-award and everything in between.